IRIS
ZICHE, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.408
EU - Europa 9.668
AS - Asia 1.548
OC - Oceania 17
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
Totale 23.666
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.389
GB - Regno Unito 3.429
IE - Irlanda 1.766
UA - Ucraina 1.237
CN - Cina 1.231
SE - Svezia 1.020
FR - Francia 591
DE - Germania 572
IT - Italia 571
FI - Finlandia 315
VN - Vietnam 109
IN - India 97
TR - Turchia 75
ES - Italia 40
BE - Belgio 39
CA - Canada 17
RU - Federazione Russa 16
AU - Australia 14
NL - Olanda 11
RO - Romania 8
BG - Bulgaria 7
AT - Austria 6
EU - Europa 6
HK - Hong Kong 6
PL - Polonia 6
GR - Grecia 5
CZ - Repubblica Ceca 4
EE - Estonia 4
JP - Giappone 4
NG - Nigeria 4
SG - Singapore 4
DK - Danimarca 3
EG - Egitto 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
TW - Taiwan 3
AZ - Azerbaigian 2
BR - Brasile 2
CH - Svizzera 2
HR - Croazia 2
MA - Marocco 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
MZ - Mozambico 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 23.666
Salva come PNG Salva come JPEG
Città #
Southend 3.237
Fairfield 1.996
Dublin 1.753
Chandler 1.074
Ashburn 1.046
Jacksonville 1.008
Woodbridge 944
Houston 881
Seattle 795
Wilmington 782
Cambridge 683
Ann Arbor 464
Princeton 364
Nanjing 311
Beijing 232
Siena 194
Boardman 157
San Diego 151
Menlo Park 148
Nanchang 126
San Mateo 115
Helsinki 112
Dong Ket 108
Fremont 101
Pune 81
Tianjin 75
Shenyang 74
Kunming 64
Izmir 61
Hebei 53
Changsha 41
Brussels 39
Florence 39
Dearborn 37
Jinan 36
Málaga 36
Norwalk 35
Jiaxing 30
Falls Church 29
London 29
Lancaster 28
New York 27
Düsseldorf 26
Redwood City 26
Rome 25
Zhengzhou 25
San Francisco 24
Shanghai 24
Hangzhou 22
Ningbo 18
Taizhou 18
Changchun 17
Toronto 14
Lanzhou 12
Prato 12
Renton 12
Tappahannock 11
Guangzhou 10
Anguillara Sabazia 9
Mestre 9
Milan 9
Venezia 9
Amsterdam 8
Kocaeli 8
Phoenix 8
Hounslow 7
Melbourne 7
Sofia 7
Atlanta 6
Canberra 6
Chicago 6
Edinburgh 6
Falkenstein 6
Kilburn 6
Washington 6
Delhi 5
Indiana 5
New Bedfont 5
Rende 5
Saint Petersburg 5
Vienna 5
Warsaw 5
Acton 4
Avezzano 4
Bonndorf 4
Dallas 4
Foiano della Chiana 4
Frankfurt am Main 4
Fuzhou 4
Hefei 4
Islington 4
Tallinn 4
Auckland 3
Bari 3
Berlin 3
Cairo 3
Central 3
Charlotte 3
Copenhagen 3
Gelsenkirchen 3
Totale 18.114
Salva come PNG Salva come JPEG
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 322
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 276
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 219
A fucose-containing O-glycoepitope on bovine and human nucleolin 218
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 205
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 195
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 184
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 182
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 181
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 178
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 175
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 175
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 172
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 169
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 164
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 163
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 160
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 159
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 158
Studying vascular angiogenesis and senescence in zebrafish embryos 154
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 154
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 154
The rabbit corneal pocket assay 148
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. 148
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 148
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 147
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 146
Differential contribution of bradykinin receptors in angiogenesis 144
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 144
Assessing vascular senescence in zebrafish. 142
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 141
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 140
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 140
Divergent effects of quercetin conjugates on angiogenesis. 138
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 138
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 138
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 138
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 136
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells. 135
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 135
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line. 132
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 132
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 131
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 129
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis. 128
In vitro and in vivo activation of endothelial cells by colony-stimulating factors. 126
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 124
The corneal pocket assay 124
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 123
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. 122
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 122
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers. 121
Analysis of the role of chemokines in angiogenesis 120
NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins 120
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 119
Role of nitric oxide in the modulation of angiogenesis 118
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 118
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. 118
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 118
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 117
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk. 117
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 117
In vitro and in vivo models to study chemokine regulation of angiogenesis 116
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth 116
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. 115
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses. 115
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 114
Absence of PAF actions increases angiogenesis 113
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 113
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability 113
Gangliosides, copper ions and angiogenic capacity of adult tissues 113
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 113
Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis. 112
Influence of lithium on mammary tumor growth in vivo 112
Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases. 112
Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation. 111
Nitric oxide in tumor angiogenesis. 111
Thapsigargin inhibits the response to acetylcholine and substance P but does not interfere with the responses to endothelium-independent agents. 111
Ceruloplasmin, copper ions, and angiogenesis. 111
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 111
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis 110
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo 109
ETB receptors promote proliferation and migration of endothelial cells 109
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 109
Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1). 109
Biological characterization of nanocomposite hydrogels 109
Effects of substance P on mesenteric lymphatic contractility in the rat 108
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. 108
Nitric oxide and angiogenesis 108
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit. 108
Constitutive and inducible nitric oxide synthase: role in angiogenesis 107
Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. 107
Role of prostaglandin E1 and copper in angiogenesis 107
Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium. 106
Hydrogen peroxide mediates endothelium-dependent dilation of coronary arterioles in obese rats on low carbohydrate diet. 106
The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. 106
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. 105
Angiogenesis and neoplastic progression in vitro. 105
Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium 105
Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF. 105
Totale 13.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.349
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.950 0 0 0 0 0 0 0 0 0 402 785 763
2019/20205.646 773 193 411 933 487 388 427 766 428 406 104 330
2020/20214.100 156 447 91 396 181 567 139 650 537 288 313 335
2021/20222.848 188 395 153 350 122 120 134 122 105 328 247 584
2022/20233.828 249 272 499 593 388 783 51 291 411 69 127 95
2023/20242.173 115 50 155 189 63 696 836 56 3 10 0 0
Totale 23.889